文献速递消化道肿瘤与早癌消化内镜

中国高风险地区食管癌风险分层内镜筛查的成本效果建模研究

Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study.
PubMed 文献 · Gastrointest Endosc · 2021-08-19

该建模研究从医疗系统视角构建马尔可夫模型,比较13种风险分层内镜筛查策略、普遍内镜筛查及不筛查的成本效果。结果显示风险分层筛查在所有年龄场景下ICER均低于人均GDP,<55岁人群评分阈值8或9最具成本效果,≥55岁人群普遍内镜筛查为最优策略。

要点

  • 风险分层内镜筛查在中国食管癌高风险地区具有成本效果。
  • 筛查年龄<55岁者,风险评分阈值8或9为最具成本效果策略。
  • 筛查年龄≥55岁者,普遍内镜筛查为最优策略。

核心结论

  • 风险分层内镜筛查具有成本效果,筛查年龄<55岁时应考虑评分阈值8或9,≥55岁者普遍内镜筛查为最优策略。

研究设计与样本

  • 从医疗系统视角构建马尔可夫模型,比较13种风险分层内镜筛查策略、普遍内镜筛查和不筛查的成本效果。
  • 设置6个10万人的队列,筛查年龄分别为40至65岁,随访至77岁。
  • 主要结局为增量成本效果比(ICER),即每获得一个质量调整生命年(QALY)的增量成本。

主要发现

  • 与不筛查相比,评分阈值降低时额外获得的QALY增加,40岁和65岁筛查分别获得49至172个和329至1147个QALY。
  • 所有年龄场景下风险分层内镜筛查的ICER均低于人均GDP。
  • 评分阈值3至13的11种风险分层策略ICER低于普遍内镜筛查。

关键数值与推荐

  • 支付意愿阈值为人均GDP(10,276美元/QALY)时,筛查年龄<55岁者评分阈值8或9的风险分层筛查最具成本效果。
  • 筛查年龄≥55岁者普遍内镜筛查最具成本效果。

临床怎么用

  • 在高风险地区可依据年龄选择筛查策略:<55岁采用风险评分阈值8或9的风险分层内镜筛查,≥55岁考虑普遍内镜筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Risk-stratified endoscopic screening (RSES) has been suggested to improve screening efficiency. We aimed to assess the cost-effectiveness of RSES and identify the optimal risk-score thresholds for once in a lifetime esophageal cancer (EC) screening in high-risk areas of China. METHODS: From a healthcare system perspective, a Markov model was constructed to compare the cost-effectiveness of 13 RSES strategies (under different score thresholds for EC risk), universal endoscopic screening strategy, and no screening. Six cohorts of 100,000 participants with different screening ages (40-65 years) were followed up to age 77 years. The incremental cost-effectiveness ratio (ICER), that is, incremental costs per quality-adjusted life-year (QALY) gained, was the primary outcome. RESULTS: Compared with no screening, as the score threshold was lowered, additionally gained QALYs increased, with 49 to 172 QALYs and 329 to 1147 QALYs gained from screening performed at 40 and 65 years, respectively. RSES in all age scenarios had ICERs less than the gross domestic product (GDP) per capita, and 11 RSES strategies with score thresholds of 3 to 13 had lower ICERs than universal endoscopic screening. At a willingness-to-pay threshold of the GDP per capita (U.S.$10,276/QALY), RSES at score thresholds of 8 or 9 and universal endoscopic screening were the most cost-effective strategies at ages <55 and ≥55 years, respectively. CONCLUSIONS: RSES is cost-effective, and score thresholds of 8 or 9 should be considered for screening ages <55 years. For individuals aged ≥55 years, universal endoscopic screening is the optimal strategy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Xia R, Li H, Shi J, et al. Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study. Gastrointest Endosc. 2021. PMID: 34418461. doi:10.1016/j.gie.2021.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。